Sensorion SA (ALSEN.PA)

EUR 0.46

(15.0%)

Operating Expenses Summary of Sensorion SA

  • Sensorion SA's latest annual operating expenses in 2023 was 27.05 Million EUR , down -1.17% from previous year.
  • Sensorion SA's latest quarterly operating expenses in 2024 Q2 was 3.01 Million EUR , down 0.0% from previous quarter.
  • Sensorion SA reported a annual operating expenses of 27.33 Million EUR in annual operating expenses 2022, up 45.11% from previous year.
  • Sensorion SA reported a annual operating expenses of 18.83 Million EUR in annual operating expenses 2021, up 73.21% from previous year.
  • Sensorion SA reported a quarterly operating expenses of 14.35 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Sensorion SA reported a quarterly operating expenses of 13.12 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Sensorion SA (2023 - 2011)

Created with Highcharts 11.1.0YearsOperating Expenses20112012201320142015201620172018201920202021202220230 EUR10000000 EUR20000000 EUR30000000 EUR

Historical Annual Operating Expenses of Sensorion SA (2023 - 2011)

Year Operating Expenses Operating Expenses Growth
2023 27.05 Million EUR -1.17%
2022 27.33 Million EUR 45.11%
2021 18.83 Million EUR 73.21%
2020 10.87 Million EUR -16.44%
2019 13.01 Million EUR -9.98%
2018 14.45 Million EUR 26.25%
2017 11.45 Million EUR 382.12%
2016 2.37 Million EUR 31.98%
2015 1.79 Million EUR -41.19%
2014 3.06 Million EUR 65.84%
2013 1.84 Million EUR 53.33%
2012 1.2 Million EUR 102.61%
2011 593.93 Thousand EUR 0.0%

Peer Operating Expenses Comparison of Sensorion SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -547.683%
ABIVAX Société Anonyme 127.37 Million EUR 78.761%
Adocia SA 15.62 Million EUR -73.099%
Aelis Farma SA 18.81 Million EUR -43.757%
Biophytis S.A. 14.33 Million EUR -88.751%
Advicenne S.A. 8.21 Million EUR -229.321%
genOway Société anonyme 16.73 Million EUR -61.628%
IntegraGen SA 5.35 Million EUR -405.439%
Medesis Pharma S.A. 1.56 Million EUR -1629.143%
Neovacs S.A. 10.34 Million EUR -161.551%
NFL Biosciences SA 4.37 Million EUR -518.462%
Plant Advanced Technologies SA 2.76 Million EUR -878.487%
Quantum Genomics Société Anonyme 1.71 Million EUR -1474.752%
Theranexus Société Anonyme 3 Million EUR -800.293%
TME Pharma N.V. 5.49 Million EUR -392.154%
Valbiotis SA 9.86 Million EUR -174.128%
TheraVet SA 1.64 Million EUR -1545.288%
Valerio Therapeutics Société anonyme 20.32 Million EUR -33.138%
DBV Technologies S.A. 89.4 Million EUR 69.741%
Genfit S.A. 54.8 Million EUR 50.636%
GeNeuro SA 14.35 Million EUR -88.432%
Innate Pharma S.A. 64.57 Million EUR 58.102%
Inventiva S.A. 120.18 Million EUR 77.49%
MaaT Pharma SA 21.59 Million EUR -25.26%
MedinCell S.A. 32.92 Million EUR 17.825%
Nanobiotix S.A. 58.92 Million EUR 54.089%
OSE Immunotherapeutics SA 23.58 Million EUR -14.688%
Poxel S.A. 28.76 Million EUR 5.949%
GenSight Biologics S.A. 32.66 Million EUR 17.166%
Transgene SA 31.23 Million EUR 13.376%
Valneva SE 134.92 Million EUR 79.949%